Recent Events & Catalysts
LeMaitre Vascular, Inc. (LMAT) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94
Benzinga · 6d ago
LeMaitre Vascular (NASDAQ:LMAT) Shares Slide on Q2 Earnings Miss
ChartMill · 6d ago
LeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript
SeekingAlpha · 6d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 7d ago
LeMaitre Vascular Sees Q4 GAAP EPS $0.75-$0.81 vs $0.78 Est; Sees Sales $71.100M-$73.100M vs $72.745M Est
Benzinga · 7d ago
LeMaitre Vascular Sees Q3 GAAP EPS $0.66-$0.71 vs $0.73 Est; Sees Sales $66.300M-$68.300M vs $69.246M Est
Benzinga · 7d ago
LeMaitre Vascular Lowers FY2026 GAAP EPS Guidance from $2.93-$3.08 to $2.84-$2.94 vs $2.97 Est; Lowers FY2026 Sales Guidance from $277.000M-$283.000M to $274.300M-$278.300M vs $279.948M Est
Benzinga · 7d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-04 · 7d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-05 · 67d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.